Literature DB >> 15804286

Complement receptors regulate lipopolysaccharide-induced T-cell stimulation.

Ziya Kaya1, Theresa Tretter, Jens Schlichting, Florian Leuschner, Marina Afanasyeva, Hugo A Katus, Noel R Rose.   

Abstract

Complement receptors type 1 and 2 (CR1 (CD35)/CR2 (CD21)) are known to enhance the adaptive immune response. In mice, CR1/CR2 are expressed on B cells, follicular dendritic cells, and activated granulocytes. Recently, we showed that a subset of CD44high and CD62Llow T cells also expresses CR1 and CR2. We now report that CR1/CR2 are detectable on both CD4+ and CD8+ subsets of T cells. Lipopolysaccharide (LPS) from Gram-negative bacteria causes polyclonal activation of B cells and stimulation of macrophages and other antigen-presenting cells. We further demonstrate that LPS induced marked up-regulation of CD25 and CD69 on T cells from CR1/CR2 sufficient (Cr+/+), but significantly lower up-regulation on T cells from CR1/CR2 deficient (Cr-/-) mice. These findings point to a novel mechanism by which CR1/CR2 modulates the activation of T cells by LPS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15804286      PMCID: PMC1782106          DOI: 10.1111/j.1365-2567.2004.02113.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

Review 1.  Induction of proliferation and cytokine production in human T lymphocytes by lipopolysaccharide (LPS).

Authors:  A J Ulmer; H Flad; T Rietschel; T Mattern
Journal:  Toxicology       Date:  2000-11-02       Impact factor: 4.221

2.  Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes.

Authors:  E Fischer; C Delibrias; M D Kazatchkine
Journal:  J Immunol       Date:  1991-02-01       Impact factor: 5.422

3.  LPS promotes CB3-induced myocarditis in resistant B10.A mice.

Authors:  J R Lane; D A Neumann; A Lafond-Walker; A Herskowitz; N R Rose
Journal:  Cell Immunol       Date:  1991-08       Impact factor: 4.868

4.  Contribution of the innate immune system to autoimmune myocarditis: a role for complement.

Authors:  Z Kaya; M Afanasyeva; Y Wang; K M Dohmen; J Schlichting; T Tretter; D Fairweather; V M Holers; N R Rose
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

5.  Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative.

Authors:  T Kinoshita; J Takeda; K Hong; H Kozono; H Sakai; K Inoue
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

6.  Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies.

Authors:  C D Tsoukas; J D Lambris
Journal:  Eur J Immunol       Date:  1988-08       Impact factor: 5.532

7.  Studies on the expression of spontaneous and induced interferons in mouse peritoneal macrophages by means of monoclonal antibodies to mouse interferons.

Authors:  F Belardelli; S Gessani; E Proietti; C Locardi; P Borghi; Y Watanabe; Y Kawade; I Gresser
Journal:  J Gen Virol       Date:  1987-08       Impact factor: 3.891

8.  T cell regulation of polyclonal B cell responsiveness. I. Helper effects of T cells.

Authors:  M G Goodman; W O Weigle
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

9.  Endotoxin-induced T lymphocyte proliferation.

Authors:  S N Vogel; M L Hilfiker; M J Caulfield
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

Review 10.  Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses.

Authors:  B Sherry; A Cerami
Journal:  J Cell Biol       Date:  1988-10       Impact factor: 10.539

View more
  7 in total

1.  Mice expressing human CR1/CD35 have an enhanced humoral immune response to T-dependent antigens but fail to correct the effect of premature human CR2 expression.

Authors:  Isabel Y Pappworth; Christine Hayes; Jason Dimmick; B Paul Morgan; V Michael Holers; Kevin J Marchbank
Journal:  Immunobiology       Date:  2011-06-25       Impact factor: 3.144

2.  App1: an antiphagocytic protein that binds to complement receptors 3 and 2.

Authors:  Paola Stano; Virginia Williams; Maristella Villani; Eugene S Cymbalyuk; Asfia Qureshi; Yuxiang Huang; Giulia Morace; Chiara Luberto; Stephen Tomlinson; Maurizio Del Poeta
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

3.  Deletion of putative intronic control sequences does not alter cell or stage specific expression of Cr2.

Authors:  Kirstin M Roundy; Janis J Weis; John H Weis
Journal:  Mol Immunol       Date:  2009-09-09       Impact factor: 4.407

4.  Canine T-zone lymphoma: unique immunophenotypic features, outcome, and population characteristics.

Authors:  D M Seelig; P Avery; T Webb; J Yoshimoto; J Bromberek; E J Ehrhart; A C Avery
Journal:  J Vet Intern Med       Date:  2014-03-21       Impact factor: 3.333

5.  Safety of photosynthetic Synechococcus elongatus for in vivo cyanobacteria-mammalian symbiotic therapeutics.

Authors:  Kiah M Williams; Hanjay Wang; Michael J Paulsen; Akshara D Thakore; Mary Rieck; Haley J Lucian; Frederick Grady; Camille E Hironaka; Athena J Chien; Justin M Farry; Hye Sook Shin; Kevin J Jaatinen; Anahita Eskandari; Lyndsay M Stapleton; Amanda N Steele; Jeffrey E Cohen; Y Joseph Woo
Journal:  Microb Biotechnol       Date:  2020-05-31       Impact factor: 5.813

6.  Endogenous Nur77 Is a Specific Indicator of Antigen Receptor Signaling in Human T and B Cells.

Authors:  Judith F Ashouri; Arthur Weiss
Journal:  J Immunol       Date:  2016-12-09       Impact factor: 5.422

7.  Indolent T-cell-rich small B-cell hepatic lymphoma in a Golden Retriever.

Authors:  Emily D Rout; Kelly L Hughes; Brendan O Boostrom; Davis M Seelig; Anne C Avery; Paul R Avery
Journal:  Clin Case Rep       Date:  2018-06-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.